These AmphPVP-BTZ-DR5-B and AmphPVP-BTZ-DR5-B-iRGD biocomposites were expected to demonstrate superior DR5 receptor internalization, efficient triggering of apoptotic cell death, and enhanced cytotoxic effects against pancreatic cancer cell lines. Here, TNFRSF10B is linked to pancreatic neoplasm.